T1	Participants 12 114	Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen
T2	Participants 177 297	subgroup of postmenopausal, estrogen receptor-positive Japanese breast cancer patients from the Pre-Operative "Arimidex"
T3	Participants 450 523	Patients with large, potentially operable, locally-advanced breast cancer
